Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Efficacy and PK/PD Relationship of Monotherapy MORAb-004 in Subjects With Metastatic Melanoma

NCT01335009 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT01335009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01335009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Efficacy and PK/PD Relationship of Monotherapy MORAb-004 in Subjects With Metastatic Melanoma
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 16, 2011
Completion date
April 10, 2020
Enrollment
76 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma